William J. Peters, CFO, EVP, and Treasurer of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH), filed a Form 4 on November 6, 2026, disclosing option exercises and open-market sales of common stock on November 4 and November 5, 2026, pursuant to a Rule 10b5-1 trading plan.
Key Highlights
- 16,000 shares exercised on Nov. 4: Peters exercised employee stock options at $13.03 per share, acquiring 16,000 shares of common stock via transaction code M.
- 16,000 shares sold on Nov. 4: All 16,000 shares were sold at $28.03 per share, reducing direct holdings to 168,707 shares.
- 11,000 shares exercised on Nov. 5: Peters exercised a second employee stock option at $17.99 per share, acquiring 11,000 shares via transaction code M.
- 12,631 shares sold on Nov. 5: These shares were sold at a weighted average price of $28.9913, in multiple transactions ranging from $28.99 to $29.00, per the filing.
- Post-transaction ownership: Following all reported transactions, Peters directly owned 167,076 shares of common stock.
- 10b5-1 plan: According to the filing, both sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Peters on March 10, 2026.
- Options fully vested: The filing states that shares subject to both exercised options "are fully vested and immediately exercisable."
Peters Exercises and Sells Amphastar Shares Under Pre-Established Trading Plan
According to the Form 4 filed with the SEC on November 6, 2026, William J. Peters, who serves as CFO, EVP, and Treasurer of Amphastar Pharmaceuticals, Inc., carried out a series of option exercises and stock sales on November 4 and November 5, 2026. The filing identifies the issuer as Amphastar Pharmaceuticals, Inc., trading on NASDAQ:AMPH.
On November 4, 2026, Peters exercised employee stock options covering 16,000 shares at an exercise price of $13.03 per share, with those options carrying an expiration date of March 16, 2030. The same day, all 16,000 acquired shares were sold at $28.03 per share, bringing his direct beneficial ownership to 168,707 shares. Following the November 4 transactions, 7,674 options under that grant remained beneficially owned.
On November 5, 2026, Peters exercised a second employee stock option covering 11,000 shares at an exercise price of $17.99 per share, with an expiration date of March 17, 2031. That same day, 12,631 shares were sold at a weighted average price of $28.9913, in multiple transactions at prices ranging from $28.99 to $29.00, inclusive, as stated in the filing. Following these transactions, Peters directly held 167,076 shares, and 67,833 options under the second grant remained. The filing notes that both sales were made under a Rule 10b5-1 trading plan Peters adopted on March 10, 2026.
What Was Disclosed
The filing reports two rounds of option exercises and stock sales by Amphastar's CFO, EVP, and Treasurer on November 4 and 5, 2026, totaling 27,000 shares exercised and 28,631 shares sold, with 167,076 shares remaining directly held afterward.



Please wait processing your request...